| 2024-01-03 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, Chief Medical Officer | 5,843 0.0065% | $29.46 | $172,135 | -12.78% | |
| 2023-01-04 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, Chief Medical Officer | 2,574 0.0028% | $37.21 | $95,779 | -3.48% | |
| 2022-01-01 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, Chief Medical Officer | 1,051 0.0013% | $112.24 | $117,964 | ||
| 2021-11-05 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, Chief Medical Officer | 2,400 0.0033% | $132.72 | $318,535 | -53.13% | |
| 2021-10-14 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, Chief Medical Officer | 2,400 0.0033% | $128.44 | $308,249 | -50.27% | |
| 2021-09-21 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, Chief Medical Officer | 2,400 0.0033% | $149.81 | $359,544 | -52.58% | |
| 2021-08-30 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, Chief Medical Officer | 2,400 0.0033% | $158.04 | $379,300 | -48.07% | |
| 2021-08-09 | Sale | Intellia Therapeutics, Inc. NTLA | EVP, Chief Medical Officer | 2,400 0.0033% | $164.05 | $393,720 | -43.95% |